No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
MMSI240517C85000
- 0.35
- 0.000.00%
15min DelayTrading Mar 18 12:18 ET
0.00High0.00Low
0.00Open0.35Pre Close0 Volume11 Open Interest85.00Strike Price0.00Turnover38.03%IV6.83%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier8DDays to Expiry0.35Time Value100Contract SizeAmericanOptions Type0.1492Delta0.0499Gamma228.26Leverage Ratio-0.0640Theta0.0027Rho34.05Eff Leverage0.0284Vega
Intraday
- 5D
- 1D
News
We Think Merit Medical Systems (NASDAQ:MMSI) Can Manage Its Debt With Ease
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it seems
Merit Medical Is Maintained at Buy by Canaccord Genuity
Merit Medical Is Maintained at Buy by Canaccord Genuity
Merit Medical Price Target Cut to $102.00/Share From $112.00 by Canaccord Genuity
Merit Medical Price Target Cut to $102.00/Share From $112.00 by Canaccord Genuity
The Analyst Landscape: 11 Takes On Merit Medical Systems
Merit Medical Systems (NASDAQ:MMSI) has been analyzed by 11 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.The table below provides a concise over
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q1 2024 Earnings Call Transcript
Express News | Piper Sandler Maintains Overweight on Merit Medical Systems, Raises Price Target to $97
Comments
Insider share sale at current price, lack of insider buying, and insignificant insider ownership suggest caution before buying the stock, despite company's profitability and profit growth.
CFO & Treasurer Of Merit Medical Systems Sold 46% Of Their Shares 2
The company's consistent but low ROCE and the increase in capital employed without a corresponding increase in returns may be factors contributing to its relatively modest stock gain. The analysis suggests looking at other options for potential multi-baggers.
1
MMSI's shares are trading above fair value due to its positive outlook. Despite overvaluation, the company's expected higher cash flow could lead to a higher share valuation.
Merit Medical Systems' strong EPS growth is attractive to investors, as is the fact that insiders hold a substantial stake in the company. Because of this, further investigation into the company's true value is recommended.
The business isn't making high-return investments despite an increase in its capital employed. Even though Merit Medical Systems is increasing its capital, diminishing returns on said capital make it less attractive as a high-value growth stock.
Read more